基于网络药理学和分子对接研究芍药苷抗帕金森病作用机制.pdf

1、本文档共57页，可阅读全部内容。
2、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

中文摘要·····································································································1

英文摘要·····································································································3

英文缩写·····································································································7

研究论文

基于网络药理学和分子对接研究芍药苷抗帕金森病作用机制

前言······································································································8

材料与方法··························································································9

结果···································································································17

附图···································································································21

附表···································································································32

讨论···································································································35

结论···································································································37

参考文献···························································································38

综述···········································································································42

致谢···········································································································55

个人简历···································································································56

中文摘要

基于网络药理学和分子对接研究芍药苷抗帕金森病作用机制

摘要

帕金森病（Parkinsonsdisease，PD）是一种复杂的多因子神经退

行性疾病，是继阿尔茨海默病之后的第二大神经退行性疾病。目前，

治疗PD的药物主要包括左旋多巴制剂、多巴胺受体激动剂、单胺氧化

酶B抑制剂、甲基转移酶抑制剂和其他如抗胆碱能类药物等，疾病后

期需要多药联合。尽管这些药物能够减轻患者症状，但需要长期服药，

该用户很懒，什么也没介绍

咨询Ta 进入空间

更多 >